Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-29 @ 11:53 AM
Study NCT ID:
NCT01258868
Status:
TERMINATED
Last Update Posted:
2019-12-03
First Post:
2010-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12-01
Start Date Type:
None
Primary Completion Date:
2016-06-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-13
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-10
First Submit QC Date:
None
Study First Post Date:
2010-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-30
Last Update Post Date:
2019-12-03
Last Update Post Date Type:
ACTUAL